Tag Archive for: Corona Virus

Pharmaceuticals vs Covid-19 | Half-Time Report by Sid Masters, Masters Pharma

As many countries continue to pass the peak of COVID-19, Masters Speciality Pharma’s Head of Licensing, Sid Masters believes now is a good time to reflect on the challenges, successes and response of the pharmaceutical industry during the pandemic.  Sid writes: Over the past few months we have seen Covid-19 wreak havoc by crippling our […]